肿瘤整形保乳术作为乳房切除术替代方案的临床与患者报告结局:ANTHEM多中心前瞻性队列研究
ANTHEM研究前瞻性纳入32个英国乳腺中心的362例浸润性/原位乳腺癌女性,评估以肿瘤整形保乳术替代乳房切除术的临床与患者报告结局。81.2%选择肿瘤整形保乳术,其中82.4%首次手术切缘阴性,仅3.9%需补行乳房切除术。肿瘤整形保乳术的大并发症率低于即刻乳房重建,容量移位技术可改善乳房满意度与心理社会健康,但两组胸壁生理健康均下降。
要点
- 肿瘤整形保乳术可使超过95%的女性避免乳房切除术。
- 肿瘤整形保乳术大并发症率低于即刻乳房重建。
- 容量移位技术可改善乳房满意度与心理社会健康,但胸壁生理健康下降。
核心结论
- 肿瘤整形保乳术可使超过95%的女性避免乳房切除术,大并发症率低于即刻乳房重建,并可能改善结局满意度。
- 对所有技术上可行的女性,肿瘤整形保乳术应作为乳房切除术的替代方案提供。
研究设计与样本
- 多中心前瞻性队列研究(ANTHEM,ISRCTN18238549),纳入32个英国乳腺中心的362例浸润性/原位乳腺癌女性。
- 研究对象为被提供肿瘤整形保乳术(容量替代或移位技术)以避免乳房切除术的女性,前瞻性收集人口学、手术、肿瘤学及3个月和12个月并发症数据。
- 参与者于基线、术后3个月和12个月完成经验证的BREAST-Q问卷,按开发者说明评分并比较各组随时间的变化。
主要发现
- 362例女性中294例(81.2%)选择肿瘤整形保乳术。
- 在报告术后切缘状态的肿瘤整形保乳术患者中,255例中210例(82.4%)首次手术后切缘阴性,仅10例(3.9%)需补行乳房切除术。
- 即刻乳房重建后大并发症显著更可能发生。
- 接受容量移位技术的肿瘤整形保乳术女性在3个月和12个月时基线「乳房满意度」和「心理社会健康」评分显著改善。
- 两组肿瘤整形保乳术女性在3个月和12个月时「胸壁生理健康」均显著下降。
临床怎么用
- 对所有技术上可行的乳腺癌女性,应将肿瘤整形保乳术作为乳房切除术的替代方案提供。
- 肿瘤整形保乳术可让超过95%的女性避免乳房切除术,且大并发症率低于即刻乳房重建。
- 容量移位技术可改善乳房满意度与心理社会健康,但需关注胸壁生理健康下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oncoplastic breast-conserving surgery may be a better option than mastectomy, but high-quality comparative evidence is lacking. The aim of the ANTHEM study (ISRCTN18238549) was to explore clinical and patient-reported outcomes in a multicentre cohort of women offered oncoplastic breast-conserving surgery as an alternative to mastectomy with or without immediate breast reconstruction. METHODS: Women with invasive/pre-invasive breast cancer who were offered oncoplastic breast-conserving surgery with volume replacement or displacement techniques to avoid mastectomy were recruited prospectively. Demographic, operative, oncological, and 3- and 12-month complication data were collected. The proportion of women choosing oncoplastic breast-conserving surgery and the proportion in whom breast conservation was successful were calculated. Participants completed the validated BREAST-Q questionnaire at baseline, 3 months after surgery, and 12 months after surgery. Questionnaires were scored according to the developers' instructions and scores for each group were compared over time. RESULTS: In total, 362 women from 32 UK breast units participated, of whom 294 (81.2%) chose oncoplastic breast-conserving surgery. Of the oncoplastic breast-conserving surgery patients in whom postoperative margin status was reported, 210 of 255 (82.4%) had clear margins after initial surgery and only 10 (3.9%) required completion mastectomy. Major complications were significantly more likely after immediate breast reconstruction. Women having oncoplastic breast-conserving surgery with volume displacement techniques reported significant improvements in baseline 'satisfaction with breasts' and 'psychosocial well-being' scores at 3 and 12 months, but both oncoplastic breast-conserving surgery groups reported significant decreases in 'physical well-being: chest' at 3 and 12 months. CONCLUSION: Oncoplastic breast-conserving surgery allows greater than 95% of women to avoid mastectomy, with lower major complication rates than immediate breast reconstruction, and may improve satisfaction with outcome. Oncoplastic breast-conserving surgery should be offered as an alternative to mastectomy in all women in whom it is technically feasible.
引用
- Davies C, Johnson L, Conefrey C, et al. Clinical and patient-reported outcomes in women offered oncoplastic breast-conserving surgery as an alternative to mastectomy: ANTHEM multicentre prospective cohort study. Br J Surg. 2024. PMID: 39718969. doi:10.1093/bjs/znae306
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。